SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 cases-Reference-Cited by-同舟云学术

SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 cases

Published:2013-07-22 Issue:1 Volume:13 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Jacquemier Jocelyne,Spyratos Frédérique,Esterni Benjamin,Mozziconacci Marie-Joëlle,Antoine Martine,Arnould Laurent,Lizard Sarab,Bertheau Philippe,Lehmann-Che Jacqueline,Fournier Cécile Blanc,Krieger Sophie,Bibeau Frédéric,Lamy Pierre-Jean,Chenard Marie Pierre,Legrain Michèle,Guinebretière Jean-Marc,Loussouarn Delphine,MacGrogan Gaëtan,Hostein Isabelle,Mathieu Marie Christine,Lacroix Ludovic,Valent Alexander,Robin Yves Marie,Revillion Françoise,Triki Magali Lacroix,Seaume Aline,Salomon Anne Vincent,de Cremoux Patricia,Portefaix Geneviève,Xerri Luc,Vacher Sophie,Bièche Ivan,Penault-Llorca Frédérique

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-13-351.pdf

Reference44 articles.

1. Loi S, de Azambuja E, Pugliano L, Sotiriou C, Piccart MJ: HER2-overexpressing breast cancer: time for the cure with less chemotherapy?. Curr Opin Oncol. 2011, 23: 547-558. 10.1097/CCO.0b013e32834bd4c9.

2. Tagliabue E, Campiglio M, Pupa SM, Balsari A, Menard S: The HER2 World: Better Treatment Selection for Better Outcome. J Natl Cancer Inst Monogr. 2011, 2011: 82-85. 10.1093/jncimonographs/lgr041.

3. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, et al: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007, 25: 118-145.

4. Lacroix-Triki M, Mathoulin-Pelissier S, Ghnassia JP, MacGrogan G, Vincent-Salomon A, Brouste V, et al: High inter-observer agreement in immunohistochemical evaluation of HER-2/neu expression in breast cancer: a multicentre GEFPICS study. Eur J Cancer. 2006, 42: 2946-2953. 10.1016/j.ejca.2006.06.020.

5. Penault-Llorca F, Adelaide J, Houvenaeghel G, Hassoun J, Birnbaum D, Jacquemier J: Optimization of immunohistochemical detection of ERBB2 in human breast cancer: impact of fixation. J Pathol. 1994, 173: 65-75. 10.1002/path.1711730111.

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Analysis of HER2 Immunohistochemistry (IHC) and Brightfield Dual-Color In Situ Hybridization (DISH) in Lymph Node Metastasized Breast Cancer;2024-09-04

2. Differentially localized protein identification for breast cancer based on deep learning in immunohistochemical images;Communications Biology;2024-08-02

3. Detection of ERBB2 and CEN17 signals in fluorescent in situ hybridization and dual in situ hybridization for guiding breast cancer HER2 target therapy;Artificial Intelligence in Medicine;2023-07

4. Targeted Approaches to HER2-Low Breast Cancer: Current Practice and Future Directions;Cancers;2022-08-03

5. MULTIMODALITY TESTING OF HER2/NEU MARKER IN BREAST CANCER: A CORRELATIVE STUDY;Towards Excellence;2022-03-31